A recent study has revealed that CCA cells, adapted to the glucose depletion microenvironment, show enhanced stemness properties and acquire resistance to gemcitabine through reactive oxygen species ROS-mediated activation of Akt (156). This evidence concerns the gene AKT1 and cholangiocarcinoma.